The term sheet became irresponsible when the investor’s ownership target required us to raise more money than the product could use well. The cheque looked attractive, but accepting it would have forced the company to grow its costs before we had earned the right to do so.
By Tuesday afternoon, I was sitting across from a respected investor with a cold coffee beside my notebook. I will leave the fund unnamed. The partner had understood the market, asked sharp questions about distribution, and moved faster than I expected. Then we reached ownership.
The fund had a target. To reach it at a valuation we could defend, the round needed to become much larger. On paper, we would gain more runway. In practice, we would inherit a new problem: finding credible uses for capital the product was not ready to absorb.
The cheque changed the company before it changed the product
The partner described the larger raise as protection. More engineers. Faster market entry. Enough cash to avoid returning to fundraising soon.
Each point sounded reasonable alone. Together, they described a company several stages ahead of the one we had actually built.
Our immediate questions were still close to the product. Which buyer felt the pain strongly enough to pay now? Which part of the workflow mattered across African, European and US customers? Where did automation remove useful work, and where did it introduce another review step? A larger balance sheet could fund more attempts, but it could not answer those questions for us.
I drew two columns in my notebook. The first contained work we already knew how to spend money on. The second contained spending we would have to invent after the round.
The second column was longer.
That was the moment the term sheet changed shape for me. I could already see the board conversation six months later. Hiring was behind plan. Growth had not caught up with the valuation. The fund would reasonably ask why we had accepted capital against a plan we could not yet execute.
The bad ending was clear: we could burn through a respectable cheque, miss the milestones attached to it, and enter the next raise with a larger team, less flexibility and the same unanswered product questions.
Ownership targets can quietly set your operating plan
Founders often treat dilution as the central negotiation. I was more concerned about what the ownership target implied after the documents were signed.
A fund needs enough ownership for a successful investment to matter inside its portfolio. That is a legitimate constraint. A founder needs enough evidence, operating capacity and market pull to deploy the corresponding cheque without manufacturing activity. That is also legitimate.
The trouble begins when those constraints do not fit.
If we accepted the larger round, our monthly costs would likely rise because holding unused capital while continuing at the same pace would be difficult to defend. New hires would need roadmaps. Market launches would need targets. Each commitment would reduce the time available to learn from customers before the organisation hardened around an assumption.
I had seen a related pattern in product work: money can make a weak signal look actionable because the team now has the capacity to act on it. The empty evidence column stays empty, while the plan around it becomes more detailed.
By the end of the meeting, the investor had not become less impressive. The mismatch had become more visible.
Saying no required a smaller story
I closed the notebook and said we could not responsibly absorb the round at the ownership level the fund required.
There was no dramatic walkout. The partner pushed back, as expected. Could we accelerate hiring? Could we enter another market earlier? Could we acquire a smaller product or team?
Those were possible uses of capital. We did not yet have evidence that they were the right uses.
For a few minutes, I wondered whether I was confusing discipline with fear. Famous funds carry their own gravity. Their name can help with hiring, introductions and the next financing conversation. Saying no meant losing those advantages, possibly for good.
The turn came when I stopped comparing the offer with having no money. I compared it with the company we would have to become immediately after accepting it.
That company needed a broader roadmap, a faster hiring plan and confidence across markets where we still had open questions. Our actual company needed sharper customer evidence and fewer commitments. The distance between those two companies was the real cost of the round.
I said no.
The decision I now write down before fundraising
Before discussing valuation, I now write a capital absorption plan in plain language. It names the decisions already made, the evidence behind them, and the work money can accelerate without creating a new strategy.
Anything outside that boundary needs its own proof.
This changes the fundraising conversation. The amount stops being a trophy or a measure of ambition. It becomes a claim about how much the company can convert into useful progress before its assumptions expire.
A smaller round can still be wrong. A larger round can be exactly right when demand, hiring capacity and distribution are ready for it. The responsible amount is the one tied to decisions the company is prepared to execute.
After the meeting, I returned to the same notebook. The two columns were still there, one short and one long. I crossed out the spending we had invented for the fund and circled the work customers had already given us reason to do.
That smaller circle was the company we could honestly build next.
Comments
No comments yet.